{
    "2019-05-30": [
        [
            {
                "time": "",
                "original_text": "康泰生物：中证鹏元终止公司可转换公司债券信用评级",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "中证鹏元",
                        "可转换公司债券",
                        "信用评级",
                        "终止"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物抛30亿定增分红仅7500万 研发费率4连降销售费用增近24倍 盈利能力下降",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "定增",
                        "分红",
                        "研发费率",
                        "销售费用",
                        "盈利能力",
                        "下降"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}